eLaws | eCases | United States Code | Federal Courts |

AbbVie - Comment

Document ID: FDA-2012-D-1145-0019
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 18 2013, at 12:00 AM Eastern Daylight Time
Date Posted: March 19 2013, at 12:00 AM Eastern Standard Time
Comment Start Date: February 4 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 18 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jx-849s-wzi8
View Document:

This is comment on Notice

Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products; Extension of Comment Period

View Comment

See attached file(s)

Attachments:

AbbVie Comments

Title:
AbbVie Comments

View Attachment:

View as format pdf

Related Comments

View All

Total: 24

Roche Diagnostics - Comment
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0011

Comment Period Closed
Mar 18,2013 11:59 PM ET

Robert A. Beckman - Comment
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0006

Comment Period Closed
Mar 18,2013 11:59 PM ET

Living Well Black Inc (LWB) - Comment
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0027

Comment Period Closed
Mar 18,2013 11:59 PM ET

AbbVie - Comment
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0019

Comment Period Closed
Mar 18,2013 11:59 PM ET

Eli Lilly and Company - Comment
Public Submission Posted: 03/19/2013 ID: FDA-2012-D-1145-0020

Comment Period Closed
Mar 18,2013 11:59 PM ET